fda ruling on semaglutide How Crackdowns Are Affecting GLP-1 Use In 2025 Live Updates on Semaglutide's Current

Robert Catania explains benefits, risks, and why close medical supervision is essential.

evaluate the translational evidence supporting GLP-1RAs as candidate disease-modifying therapies for neurodegenerative diseases in this installment to the JCIs Review

Assumptions on how long diabetes is prevented: four years (which comes from tirzepatide clinical trials) vs

Tirzepatide, sold under the name Mounjaro, is among a handful of drugs with big buzz for their weight loss results, and approval for obesity could be a huge revenue source for Eli Lilly in the future.

They suppress post-prandial glucagon release, delay stomach emptying, and increase insulin sensitivity